Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 2/20 | 0.54 |
| ▸ | EGFR | P00533 | 2/20 | 0.48 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.48 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.48 |
| ▸ | ABL1 | P00519 | 1/20 | 0.48 |
| ▸ | HCK | P08631 | 1/20 | 0.48 |
| ▸ | SRC | P12931 | 1/20 | 0.48 |
| ▸ | KDR | P35968 | 1/20 | 0.48 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.48 |
| ▸ | MTOR | P42345 | 1/20 | 0.48 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.48 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.48 |
| ▸ | PRKDC | P78527 | 1/20 | 0.48 |
| ▸ | NCF1 | P14598 | 1/20 | 0.43 |
| ▸ | SOS2 | Q07890 | 1/20 | 0.42 |
| ▸ | MAP4K4 | O95819 | 6/20 | 0.42 |
| ▸ | ATM | Q13315 | 2/20 | 0.40 |
| ▸ | MAPKAPK2 | P49137 | 2/20 | 0.40 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.39 |
| ▸ | CLK1 | P49759 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25556184 | 0.87 | NR4A2 (0.56) | NR4A2EGFRPIK3CAPIK3CDABL1 | |
| SCHEMBL29061683 | 0.80 | MAP4K4 (0.60) | NR4A2EGFRPIK3CAPIK3CDABL1 | |
| SCHEMBL4151090 | 0.80 | MAP4K4 (0.60) | NR4A2EGFRPIK3CAPIK3CDABL1 | |
| SCHEMBL12545963 | 0.77 | NR4A2 (0.56) | NR4A2EGFRPIK3CAPIK3CDABL1 | |
| SCHEMBL21508010 | 0.76 | OGA (0.41) | EGFRPIK3CAPIK3CDABL1HCK | |
| SCHEMBL4146183 | 0.75 | NR4A2 (0.50) | NR4A2EGFRPIK3CAPIK3CDABL1 | |
| SCHEMBL18703931 | 0.75 | TGFBR1 (0.49) | NR4A2EGFRPIK3CAPIK3CDABL1 | |
| SCHEMBL4153922 | 0.74 | NR4A2 (0.53) | NR4A2EGFRPIK3CAPIK3CDABL1 | |
| SCHEMBL4139488 | 0.74 | NR4A2 (0.49) | NR4A2EGFRPIK3CAPIK3CDABL1 | |
| SCHEMBL5758549 | 0.73 | NR4A2 (0.56) | NR4A2EGFRPIK3CAPIK3CDABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090069338-A1 | Method for predicting skin sensitizing activity of compounds | DICKSON JR JOHN K | 2009-03-12 | — | — | US | disclosed |
| US-7452887-B2 | Quinoline- and isoquinoline-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof | AMPHORA DISCOVERY CORPORATION (US) | 2008-11-18 | — | — | US | disclosed |
| US-20060009460-A1 | Quinoline- and isoquinoline-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof | AGRIUS GROUP, LLC. | 2006-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069338-A1 | Method for predicting skin sensitizing activity of compounds | ATP5ME, ABCG2, ATP5MG | NR4A2 1882/4885EGFR 4447/4885PIK3CA 1069/4885 |
| US-20060009460-A1 | Quinoline- and isoquinoline-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof | ATP5ME, ATP5MG, ATP5MK | NR4A2 3517/4885EGFR 4792/4885PIK3CA 536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.